Home » Topics » Regulatory » Patents

Patents
RSS

BioWorld MedTech Patent Highlights: Week 27

From Current Patent Gazette

July 15, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Amgen describes new PRMT5 inhibitors

July 15, 2022

Zydus Lifesciences identifies new PCSK9 inhibitors

July 15, 2022

GlaxoSmithKline synthesizes new Nav1.8 channel blockers

July 15, 2022

Pandeia Therapeutics patents new GPR88 agonists

July 15, 2022

Chiesi Farmaceutici discloses new ROCK inhibitors

July 15, 2022

Heptares Therapeutics divulges new histamine H4 receptor antagonists

July 14, 2022

Janssen Pharmaceutica identifies new Mcl-1 inhibitors

July 14, 2022

Pfizer synthesizes IL-2 production inhibitors

July 14, 2022

Merck & Co. discloses new DNA polymerase inhibitors

July 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...